U-Blot® Research Grade FulranumabCat. No. WA2884$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade FulranumabCat. No. WA2884
U-Blot® Research Grade FrunevetmabCat. No. WA2883
U-Blot® Research Grade FrovocimabCat. No. WA2882
U-Blot® Research Grade FrexalimabCat. No. WA2881
U-Blot® Research Grade FresolimumabCat. No. WA2880
U-Blot® Research Grade FreneslerbartCat. No. WA2879
U-Blot® Research Grade FremanezumabCat. No. WA2878
U-Blot® Research Grade ForimtamigCat. No. WA2877
U-Blot® Research Grade ForavirumabCat. No. WA2876
U-Blot® Research Grade ForalumabCat. No. WA2875
U-Blot® Research Grade FontolizumabCat. No. WA2874
U-Blot® Research Grade FlotetuzumabCat. No. WA2873